Footsie edges higher
GlaxoSmithKline gave investors a dose of good news today as the drugs giant prevented the London market from closing in negative territory.
The heavyweight stock proved to be the star performer of the session, rising 6% after posting strong first quarter figures and announcing a deal with American regulators to restart production of two key treatments.
CONNECT WITH US TODAY
Be the first to know the latest news and updates